Introduction: Who Should Undergo Diagnostics

Clear cell papillary renal cell tumor typically doesn’t cause obvious symptoms in its early stages, which means most people don’t know they have it until it’s discovered by chance. The majority of cases are found when doctors order imaging tests for unrelated health concerns, such as checking for kidney stones or investigating abdominal pain.^[1] This is actually fortunate, because it means tumors are often caught early before they cause any problems.

If you notice certain warning signs, your doctor may recommend diagnostic tests. Blood in your urine, which doctors call hematuria, is one of the most important signals that needs further investigation.^[1] Other symptoms that might prompt testing include unexplained tiredness, fever, flank pain on the side of your body where the kidney is located, or an unusual lump you can feel in that area. However, it’s important to understand that many people with CCPRCT never experience any of these symptoms.

People with certain risk factors should be particularly attentive to their kidney health. Those with high blood pressure, chronic kidney disease, or end-stage renal disease are at higher risk for developing kidney tumors, including CCPRCT.^[2] In fact, this type of tumor was first identified in 2006 in a patient with end-stage renal disease, though it’s now known to occur in people without kidney disease as well.^[3]

Because CCPRCT accounts for only about 1 to 4 percent of all kidney cancers, most doctors won’t suspect it specifically when ordering tests. Rather, they’ll be looking for any kidney abnormalities that need attention. This is one reason why routine health checkups and following up on any unusual symptoms with your primary care doctor is so important.

Diagnostic Methods

Diagnosing clear cell papillary renal cell tumor involves several steps, starting with imaging tests and often ending with examination of tissue under a microscope. The process helps doctors not only find the tumor but also distinguish it from other types of kidney cancer and determine the best course of treatment.

Imaging Tests

The first tool doctors use to detect kidney tumors is medical imaging. When a doctor suspects a kidney problem, they will typically order a computed tomography scan, commonly called a CT scan. This test uses X-rays to create detailed, three-dimensional pictures of your kidneys and the area around them.^[4] Many kidney tumors are discovered this way, even when doctors are looking for something completely different, like checking for appendicitis or investigating back pain.

A CT scan for kidney evaluation usually involves something called triple-phase imaging with contrast. This means the scan captures images at three different times after a special dye is injected into your vein. The dye, called contrast material, helps different tissues show up more clearly on the images. If you’ve ever had an allergic reaction to contrast dye or iodine, make sure to tell your doctor before the test.^[4]

Magnetic resonance imaging, or MRI, is another imaging option that uses powerful magnets and radio waves instead of X-rays to create pictures of your body. Doctors might choose an MRI instead of a CT scan in certain situations, such as when they need to check whether the tumor has grown into major blood vessels near the kidney. During an MRI, you’ll need to lie still inside a large tube-shaped machine for anywhere from 15 to 90 minutes. If you feel anxious in enclosed spaces, let your doctor know beforehand so they can help make you more comfortable.^[4]

Ultrasound is a simpler, non-invasive test that uses sound waves to create images of your kidneys. It’s particularly useful for distinguishing between solid tumors and fluid-filled cysts. This test doesn’t involve any radiation or needles, making it a safe option for many patients.^[1]

Physical Examination and Medical History

Before ordering any imaging tests, your doctor will perform a thorough physical examination. They’ll check your vital signs including blood pressure, temperature, weight, and pulse. They may also feel your abdomen to check for lumps or enlarged organs. During this visit, your doctor will ask detailed questions about your overall health, any medications you take, and whether any family members have had kidney cancer or other related diseases.^[4]

Blood and Urine Tests

Laboratory tests play an important supporting role in diagnosis. Blood tests can show how well your kidneys are functioning and check your overall health. A complete blood count measures the levels of different types of cells in your blood, including red blood cells, white blood cells, and platelets. Blood chemistry tests look at things like kidney function markers and electrolyte levels such as sodium and potassium.^[4]

A simple urine test, called urinalysis, can detect blood or excess protein in your urine, both of which might signal kidney problems. This test is quick and painless – you simply provide a urine sample that gets analyzed in a laboratory.^[4]

Kidney Biopsy

While imaging tests can show that you have a kidney tumor, they usually cannot tell whether the mass is cancerous or what specific type of kidney cancer it might be. To make this determination, doctors need to examine actual tumor tissue under a microscope. This is done through a procedure called a biopsy.^[1]

During a kidney biopsy, a doctor uses a thin needle to remove a small sample of tissue from the tumor. A specialist called a pathologist then examines this tissue under a microscope, looking at the structure and characteristics of the cells. For CCPRCT, the pathologist will see distinct features: the tumor cells appear clear, like bubbles, under the microscope, and they form particular patterns called tubular and papillary structures. The cancer cells also have nuclei that line up in rows away from the basement membrane of the cells.^[2]

One helpful diagnostic tool is immunohistochemistry, a special technique where the pathologist applies different stains to the tissue sample. CCPRCT typically shows positive staining for a protein marker called cytokeratin 7, also known as CK7. This helps distinguish it from other types of kidney cancer, particularly clear cell renal cell carcinoma, which is the most common type.^[2]

It’s worth noting that not all kidney tumors require a biopsy before treatment. In some cases, especially when imaging clearly shows a tumor and the patient is healthy enough for surgery, doctors may recommend removing the tumor first and examining it afterward. This approach allows diagnosis and treatment to happen in one step. Studies show that as many as 4 out of 10 small kidney tumors (those less than 4 centimeters) turn out to be noncancerous, so getting tissue for examination is important for making the right treatment decisions.^[4]

Staging Tests

Once CCPRCT is confirmed, doctors need to determine whether the cancer has spread beyond the kidney, a process called staging. This is crucial for planning treatment. A chest X-ray or chest CT scan checks whether cancer has spread to the lungs. If there’s concern about spread to bones, a bone scan might be ordered. This test involves injecting a small amount of radioactive material into a vein, waiting about three hours, and then using a special camera to look for areas where the material has collected in the bones.^[4]

Fortunately, CCPRCT has very good boundaries and is usually surrounded by a capsule-like layer, and research shows that metastasis or spread to other parts of the body has not been reported with this tumor type.^[2] This makes CCPRCT quite different from more aggressive kidney cancers and contributes to its excellent prognosis.

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or compare different treatment approaches. While CCPRCT is a well-recognized tumor type, it remains relatively rare, and researchers continue to study the best ways to manage it. If you’re considering participating in a clinical trial, you’ll need to undergo specific diagnostic tests to determine if you qualify.

Standard Qualification Criteria

Clinical trials typically require confirmed diagnosis through pathology examination. This means you’ll need to have had either a biopsy or surgical removal of your tumor, with tissue that a pathologist has examined and classified as CCPRCT. The pathology report becomes an essential document for trial enrollment.^[3]

Most trials also require complete imaging studies to document the size and location of the tumor and to confirm whether cancer has spread. This usually includes a chest CT scan, an abdominal CT scan, and sometimes an MRI. These baseline images help researchers track how well the treatment is working over time.^[4]

Performance Status Assessment

Clinical trials need to ensure that participants are healthy enough to tolerate the study treatment. Your doctor will assess what’s called your functional status or performance status – essentially, how well you can carry out daily activities. This involves checking whether you can care for yourself, work, and move around independently.^[4]

Laboratory Requirements

Before you can join a trial, researchers need to know that your organs are functioning well enough to handle the treatment being studied. This typically requires blood tests to check your kidney function, liver function, and blood cell counts. Since CCPRCT affects the kidneys, understanding how well your remaining kidney tissue is working is particularly important.^[4]

Because CCPRCT tends to be discovered at small sizes and early stages, with a median tumor size of just 1.2 centimeters in one study, many patients with this tumor type are good candidates for clinical trials focused on less invasive treatments or active surveillance approaches.^[3]

Genetic Testing

Some clinical trials may require genetic testing, particularly if they’re studying targeted therapies that work on specific genetic changes. While most cases of CCPRCT occur randomly without a clear cause, some people have inherited genetic conditions that increase their risk. Your doctor might recommend genetic testing if you were diagnosed with CCPRCT at a young age or if you have multiple tumors.^[4]